News About: Pharm. Industry
How Korean listed pharmas with net income in 1Q?
While KOSPI listed pharmaceutical companies had a highly increased net income on average in the 1st quarter of this year year-on-year, KOSDAQ listed pharmaceutical companies met a huge decrease. When it comes to the n...
Il Yang Pharm exports acid reflux therapy ‘Noltec’ to Mongolia for first time
Il Yang Pharm(CEO Dong-Yeon Kim) announced on the 24th ‘Noltec(generic name: ilaprazole),’ a new drug for the treatment of acid reflux, was exported to Mongolia for the first time.
This export, the 5th on, of the pro...
How Korean listed pharmas did with operating profits?
In the 1st quarter of this year, KOSPI listed pharmaceutical companies had an increase of over 10% in operating profits year-on-year, but KOSDAQ listed pharmaceutical companies had a negative figure in the same catego...
Daewoong Pharmaceutical acquires Canadian GMP approval for Nabota factory
The Daewoong Pharmaceutical’s(CEO Seung-Ho Jeon) Nabora factory acquired the cGMP approval from the U.S. FDA on the last 15th, and acquired the GMP approval from the Health Canada on the 18th.
Daewoong Pharmaceutical...
Female officers at listed pharmas show outstanding activities in management, R&D and marketing
The women officer ratio at listed pharmaceutical companies is only 8%, but they are evaluated to distinguish themselves with outstanding activities in various fields, such as sales, marketing and R&D.
Yakup Shinmoon(...
How listed pharmaceutical companies spent on SG&A expenses in 1st quarter?
In the 1st quarter of this year, KOSDAQ listed pharmaceutical companies had a significantly higher average SG&A(selling, general and administrative) expense increase rate compared to the same quarter of the last year ...
‘Big 5’ pharmaceutical companies struggling with overseas sales/exports
The ‘Big 5’ pharmaceutical companies had differing results in overseas sales & exports in this 1st quarter.
GC Pharm and Hanmi Pharm had an increase, but the rest failed to do so. When it comes to the ratio of overse...
Pfizer Pharmaceuticals Korea signs co-promotion of ‘Prevenar 13’ with CKD
Pfizer Pharmaceuticals Korea(CEO Dong-Wook Oh) and Chong Kun Dang(CEO Young-Joo Kim, CKD) singed a Korean co-promotion partnership agreement of ‘Prevenar®13’ adult products, a Pfizer Pharmaceuticals Korea’s pneumococc...
51 pharmas selected as ‘2018 Hidden Champions’
51 pharmaceutical companies, such as Yuyu Pharma, UNIMED and Medytox, were selected as the 2018 hidden champions. Distribution companies were selected more with 255 companies.
Yakup Shinmoon(www.yakup.com) analyzed t...
How ‘Big 5’ pharmas did with R&D expenses in 1st quarter?
The ‘Big 5’ pharmaceutical companies’ amount spent on R&D in this 1st quarter was narrowly increased year-on-year. The percentage of the amount to sales passed 12% on average. While Green Cross, Hanmi Pharm and Daewoo...
